JP2011516610A5 - - Google Patents

Download PDF

Info

Publication number
JP2011516610A5
JP2011516610A5 JP2011505149A JP2011505149A JP2011516610A5 JP 2011516610 A5 JP2011516610 A5 JP 2011516610A5 JP 2011505149 A JP2011505149 A JP 2011505149A JP 2011505149 A JP2011505149 A JP 2011505149A JP 2011516610 A5 JP2011516610 A5 JP 2011516610A5
Authority
JP
Japan
Prior art keywords
optionally substituted
alkyl
compound
group
optionally
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2011505149A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011516610A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2009/040567 external-priority patent/WO2009134616A2/en
Publication of JP2011516610A publication Critical patent/JP2011516610A/ja
Publication of JP2011516610A5 publication Critical patent/JP2011516610A5/ja
Pending legal-status Critical Current

Links

JP2011505149A 2008-04-15 2009-04-14 Ｃ型肝炎ウイルス複製の新規な阻害剤 Pending JP2011516610A (ja)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
US4521408P 2008-04-15 2008-04-15
US4521908P 2008-04-15 2008-04-15
US61/045,219 2008-04-15
US61/045,214 2008-04-15
US10985608P 2008-10-30 2008-10-30
US61/109,856 2008-10-30
US11791608P 2008-11-25 2008-11-25
US61/117,916 2008-11-25
US14833709P 2009-01-29 2009-01-29
US61/148,337 2009-01-29
PCT/US2009/040567 WO2009134616A2 (en) 2008-04-15 2009-04-14 Novel inhibitors of hepatitis c virus replication

Publications (2)

Publication Number Publication Date
JP2011516610A JP2011516610A (ja) 2011-05-26
JP2011516610A5 true JP2011516610A5 (enExample) 2012-06-07

Family

ID=41078055

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011505149A Pending JP2011516610A (ja) 2008-04-15 2009-04-14 Ｃ型肝炎ウイルス複製の新規な阻害剤

Country Status (10)

Country Link
US (1) US20090257979A1 (enExample)
EP (1) EP2283002A2 (enExample)
JP (1) JP2011516610A (enExample)
KR (1) KR20110004439A (enExample)
CN (1) CN102026990A (enExample)
AU (1) AU2009241514A1 (enExample)
BR (1) BRPI0911259A2 (enExample)
CA (1) CA2720846A1 (enExample)
MX (1) MX2010011307A (enExample)
WO (1) WO2009134616A2 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LT2056675T (lt) 2006-10-12 2019-05-27 Galera Labs, Llc Burnos gleivinės mukozito gydymo būdai
CN102666537A (zh) * 2009-10-20 2012-09-12 艾格尔生物制药股份有限公司 治疗黄病毒科病毒感染的氮杂吲唑
TW201121968A (en) * 2009-11-09 2011-07-01 Intermune Inc Novel inhibitors of hepatitis C virus replication
CA3120505C (en) 2011-09-26 2024-11-12 Galera Labs, Llc METHODS OF TREATING DISEASES
CN104023726A (zh) 2011-10-21 2014-09-03 艾伯维公司 用于治疗hcv的一种或多种daa的联合治疗(例如，与abt-072或abt-333)
US8492386B2 (en) 2011-10-21 2013-07-23 Abbvie Inc. Methods for treating HCV
US8466159B2 (en) 2011-10-21 2013-06-18 Abbvie Inc. Methods for treating HCV
DE112012003510T5 (de) 2011-10-21 2015-03-19 Abbvie Inc. Verfahren zur Behandlung von HCV umfassend mindestens zwei direkt wirkende antivirale Wirkstoffe, Ribavirin aber nicht Interferon
WO2015018797A2 (en) * 2013-08-05 2015-02-12 Haplogen Gmbh Antiviral compounds
WO2016148512A1 (ko) * 2015-03-16 2016-09-22 마이크로엑츄에이터(주) 카메라 모듈에 사용되는 필터전환 장치 및 카메라 모듈을 포함하는 모바일 기기
UA126788C2 (uk) 2015-08-11 2023-02-08 Ґалера Лебз, Елелсі Комплексні сполуки, що містять макроциклічне кільце пентаази, які мають пероральну біодоступність
JP7129703B2 (ja) 2016-04-28 2022-09-02 エモリー ユニバーシティー アルキン含有ヌクレオチド及びヌクレオシド治療組成物並びにそれらに関連した使用
MX393974B (es) 2016-05-03 2025-03-24 Galera Labs Llc Terapia de combinacion para tratamiento de cancer.
JP7166634B2 (ja) 2016-09-01 2022-11-08 ガレラ・ラブス・リミテッド・ライアビリティ・カンパニー ペンタアザ大環状環複合体およびアスコルビン酸化合物による組み合わせ癌療法
EA201992431A1 (ru) 2017-10-13 2020-03-13 ГАЛЕРА ЛЭБЗ, ЭлЭлСи Комбинированная иммунотерапия рака с использованием пента-аза-макроциклического кольцевого комплекса

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6025984A (ja) * 1983-07-22 1985-02-08 Tokyo Inst Of Technol ベンゾチアジアジン誘導体の製造方法
JPH0216448A (ja) * 1988-07-04 1990-01-19 Fuji Photo Film Co Ltd 化学物質の分配係数の推算処理方法
CZ220498A3 (cs) * 1996-01-17 1998-11-11 Novo Nordisk A/S Deriváty 1,2,4-thiadiazinu a 1,4-thiazinu, příprava a použití
US6242443B1 (en) * 1996-06-21 2001-06-05 Novo Nordisk Ais 1,2,4-benzothiadiazine derivatives, their preparation and use
US6156700A (en) * 1997-09-17 2000-12-05 American Cyanmid Company 3-(1,2-Benzisothiazol- and isoxazol-5-yl)-2,4(1H,3H)-pyrimidinedione or thione and 3-(1,2-benzisothiazol- and isoxazol-5-yl)-4(3H)-pyrimidinone or thione herbicidal agents
US6943159B1 (en) * 1998-02-18 2005-09-13 Neurosearch A/S Compounds and their use as positive AMPA receptor modulators
US20040097492A1 (en) * 2002-11-01 2004-05-20 Pratt John K Anti-infective agents
SI1560827T1 (sl) * 2002-11-01 2011-04-29 Abbott Lab Antiinfekcijska sredstva
US7902203B2 (en) * 2002-11-01 2011-03-08 Abbott Laboratories, Inc. Anti-infective agents
US20050075331A1 (en) * 2003-10-06 2005-04-07 Pratt John K. Anti-infective agents
US20040162285A1 (en) * 2002-11-01 2004-08-19 Pratt John K. Anti-infective agents
US20040242568A1 (en) * 2003-03-25 2004-12-02 Syrrx, Inc. Dipeptidyl peptidase inhibitors
US7378414B2 (en) * 2003-08-25 2008-05-27 Abbott Laboratories Anti-infective agents
WO2006021340A1 (en) * 2004-08-23 2006-03-02 F.Hoffmann-La Roche Ag Heterocyclic antiviral compounds
US7846915B2 (en) * 2004-10-20 2010-12-07 Resverlogix Corporation Stilbenes and chalcones for the prevention and treatment of cardiovascular diseases
WO2006093801A1 (en) * 2005-02-25 2006-09-08 Abbott Laboratories Thiadiazine derivatives useful as anti-infective agents
MX2007013415A (es) * 2005-05-04 2008-01-15 Hoffmann La Roche Compuestos antivirales heterociclicos.
WO2007150001A1 (en) * 2006-06-22 2007-12-27 Anadys Pharmaceuticals, Inc. Pyrro[1,2-b]pyridazinone compounds
JP4199273B2 (ja) * 2006-08-29 2008-12-17 本田技研工業株式会社 車両状態推定装置
TW200840572A (en) * 2006-12-12 2008-10-16 Anadys Pharmaceuticals Inc 5,6-dihydro-1H-pyridin-2-one compounds
US20080188466A1 (en) * 2006-12-21 2008-08-07 Anadys Pharmaceuticals, Inc. Pyridazinone compounds
PT2118074E (pt) * 2007-02-01 2014-03-20 Resverlogix Corp Compostos para a prevenção e tratamento de doenças cardiovasculares
US20080227774A1 (en) * 2007-03-15 2008-09-18 Frank Ruebsam 5,5-disubstituted-indolizinone compounds
US7834009B2 (en) * 2007-08-27 2010-11-16 Anadys Pharmaceuticals, Inc. 4-hydroxy-5,6-dihydro-1H-pyridin-2-one compounds
TWI438206B (zh) * 2008-06-10 2014-05-21 Anadys Pharmaceuticals Inc 〔１，２，４〕噻二１，１二氧化物化合物

Similar Documents

Publication Publication Date Title
JP2011219498A5 (enExample)
JP2013523765A5 (enExample)
JP2013503846A5 (enExample)
EA200901241A1 (ru) Соединения для лечения гепатита с
EA201290053A1 (ru) Ингибиторы вирусов flaviviridae
JP2010524932A5 (enExample)
EA201491179A1 (ru) 2',4'-дифтор-2'-метил замещенные нуклеозидные производные в качестве ингибиторов репликации рнк вируса гепатита с
NO20082934L (no) Antivirale nukleotider
JP2016506960A5 (enExample)
JP2012041349A5 (enExample)
JP2014500265A5 (enExample)
JP2013537203A5 (enExample)
JP2012519691A5 (enExample)
WO2008085508A3 (en) Nucleoside aryl phosphoramidates for the treatment of rna-dependent rna viral infection
JP2017515901A5 (enExample)
JP2016505595A5 (enExample)
EA025252B1 (ru) Способы и соединения для лечения вирусных инфекций paramyxoviridae
TR201815272T4 (tr) İnfluenza virüs replikasyonu inhibitörleri.
JP2014503516A5 (enExample)
JP2011520906A5 (enExample)
WO2007095269A3 (en) Nucleoside aryl phosphoramidates for the treatment of rna-dependent rna viral infection
NZ593712A (en) Intermediates for synthesising nucleoside aryl phosphoramidates
EA200802346A1 (ru) Циклопропилконденсированные индолобензазепиновые ингибиторы белка ns5b вируса гепатита с
MX2010002904A (es) N-fenil-dioxo-hidropirimidinas utiles como inhibidores de virus de hepatitis c (hcv).
JP2008523082A5 (enExample)